KS
Highly rated in
13
conditions
Highly rated in
13
conditions
Check Dr. Kathryn J. Swoboda's experience treating your condition:
About Dr. Kathryn J. Swoboda

Kathryn Swoboda is a Neurologist and a Medical Genetics expert in Boston, Massachusetts. Swoboda has been practicing medicine for over 33 years and is highly rated in 13 conditions, according to our data. Her top areas of expertise are Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 1, and Alternating Hemiplegia of Childhood. She is licensed to treat patients in Massachusetts and Utah. Swoboda is currently accepting new patients.

Her clinical research consists of co-authoring 127 peer reviewed articles and participating in 10 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Kathryn J. Swoboda it is best to call her office and ask if your insurance is accepted.


Dr. Kathryn J. Swoboda accepts the following insurance:

  •  Ambetter
  •  Anthem

Call to see if your plan is accepted.
Locations
15 Parkman St, Suite 720, Boston, MA 02114
Background & Education
Graduate Institution
Other, 1990
Specialties
Neurology
Medical Genetics
Pediatrics
Licenses
Psychiatry & Neurology in UT
Hospital Affiliations
Massachusetts General Hospital
Languages Spoken
English
Spanish
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants With Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy With Multiple Copies of SMN2
Prospective Evaluation of Infants With Spinal Muscular Atrophy: SPOT SMA
Prospective Controlled Trial of Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy (VALIANTSMA) Study
Prospective Phase I/II Study to Evaluate Effects of Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy
Phase I/II Trial of Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy Type I (CARNI-VAL Type I)
Single-center Phase I/II Trial of Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO Trial)
Multi-center Phase II Trial of Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy (SMA CARNI-VAL Trial)
View 9 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors